Mechanical Ventilation

Top Story

Benefits of caffeine treatment in premature infants persist into childhood

Benefits of caffeine treatment in premature infants persist into childhood
August 1, 2017

The use of caffeine for the prevention of bronchopulmonary dysplasia and to shorten the duration of assisted ventilation in premature newborns effectively improves expiratory flow rates at age 11 years, according to a study published in the American Journal of Respiratory and Critical Care Medicine.

“Infants born very preterm — less than 32 weeks’ gestational age — or less than 1,500 g have worse expiratory air flow in childhood and adulthood than those born at term or of normal birth weight,” Lex W. Doyle, MD, professor of neonatal pediatrics at the Royal Women’s Hospital Melbourne and head of the Australian National Health and Medical Research Council’s Center of Research Excellence in Newborn Medicine, and colleagues wrote.

In the Journals

Multifaceted intervention prevents ventilator-associated pneumonia

May 31, 2017
A multifaceted intervention which included training and coaching on evidence-based mediations and safety practices resulted in reductions in ventilator-associated…
In the Journals

High-flow oxygen therapy noninferior to noninvasive ventilation

November 4, 2016
High-flow conditioned oxygen therapy was not inferior to noninvasive ventilation for reducing reintubation and postextubation respiratory failure in patients at…
Meeting News

RSV morbidity increases following AAP revised guidelines to restrict palivizumab

November 3, 2016
NEW ORLEANS – RSV morbidity among infants at 29 to 34 weeks’ gestation increased significantly when palivizumab prophylaxis use was less restricted
More Headlines »
Feature Article

Manifestations of Food Allergy in Infants and Children

Pediatric Annals, August 2008, Volume 37 Issue 8
Parents frequently report that their children have adverse reactions to foods. Pediatricians must be familiar with the…
More »
Video
Meeting News

VIDEO: Additional treatment with ALK inhibitor after progression shows promise in non-small cell lung cancer

September 18, 2017
More »
Advertisement
Advertisement